用户名: 密码: 验证码:
针灸联合柳氮磺胺吡啶治疗强直性脊柱炎的临床研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:
     通过临床试验研究,观察电针夹脊穴及隔附子饼温和灸对柳氮磺胺吡啶(SASP)的增效减毒作用及其治疗强直性脊柱炎(AS)的机理,进一步探索中西医结合治疗强直性脊柱炎的安全有效方案。
     方法:
     1临床资料:所有强直性脊柱炎患者均来源于武汉市中医院风湿科专科门诊及住院部。自2007年5月至2008年2月,共收治强直性脊柱炎患者60例,采用随机、阳性药物平行对照的设计方法,分为试验组和对照组,其中试验组30例,对照组30例。
     2治疗方法:①对照组(SASP组):30例,给予柳氮磺胺吡啶口服,第一周每次0.25g,第二周起为0.5g,第三周起为0.75g直至疗程结束,每日3次,共12周。②试验组(SASP+针灸组):30例,在对照组治疗之上再给予电针及隔物温和灸,治疗12周后观察疗效。③个别病人关节疼痛难忍时,酌情临时加服洛索洛芬钠,每次60mg,每日三次,不作常规治疗(症状减轻则停药)。此外,不使用与治疗本病相关的其他的中、西药物。
     3观测指标:安全性指标包括一般体检、心、肺、肝、肾功能及血、尿、便常规等检查;疗效指标包括①主要症状:腰骶疼痛、脊背疼痛、腰脊活动受限、腰背晨僵、关节疼痛、关节肿胀、腰膝酸软困重、发热。⑦主要体征:疼痛10cm数值表、枕墙距、指地距、Schober试验、胸廓活动度、“4”字试验、骨盆挤压、分离试验。④实验室指标:HLA-B27、ESR、CRP、IgA、ALP。④放射学检查:双侧骶髂关节X线正位片。
     4统计方法:采用SPSS13.0软件包进行数据统计分析,计量资料组内比较采用配对均数t检验,组间比较采用两独立样本均数t检验;等级资料用Ridit检验,分类资料采用X~2检验,P<0.05被认为所检验的差别具有统计学意义。
     结果:
     两组共60例患者均完成疗程,依从性良好,未出现脱落、剔除病例。
     1两组患者治疗后总疗效经分析,试验组总有效率93.33%,控显(近期控制和显效)率66.67%;对照组总有效率76.67%,控显率40%,两组总疗效比较有统计学意义(P<0.05)。
     2两组患者治疗后中医证候疗效经分析,试验组总有效率86.67%,控显率56.67%;对照组总有效率76.67%,控显率22.22%,两组中医证候疗效比较有统计学意义(P<0.05)。
     3临床症状疗效方面,试验组治疗前后比较均有显著性差异(P<0.05);对照组除外周关节肿胀一项积分值治疗前后比较无显著性差异(P>0.05)外,其余各项主、次症积分治疗前后比较均有显著性差异(P<0.05);治疗后组间比较,均有显著性差异(P<0.05)。
     4主要体征比较,两组患者的疼痛10cm数值表、枕墙距、指地距、Schober试验及胸廓活动度方面,试验组治疗前后比较有显著性差异(P<0.05),对照组治疗前后比较亦有显著性差异(P<0.05),且治疗后两组患者组间比较有显著性差异(P<0.05);“4”字试验、骨盆挤压、分离试验方面,治疗后两组患者组间比较有显著性差异(P<0.05)。
     5实验室指标方面,以ESR、CRP、IgA、ALP作为观察指标,试验组治疗前后ESR、CRP、IgA数值有显著性差异(P<0.05),ALP有非常显著性差异(P<0.01);对照组治疗前后ESR、CRP、IgA、ALP数值有显著性差异(P<0.05);治疗后组间比较ESR、CRP、IgA亦有显著性差异(P<0.05),ALP有非常显著性差异(P<0.01)。
     6骶髂关节X线正位片方面,治疗后两组骶髂关节X线正位片改变无明显差异(P>0.05)。
     7治疗后不良反应方面,试验组5例患者出现短暂性轻度消化道不适;对照组2例患者出现中度不良反应,12例患者出现轻度消化道不适。两组不良反应情况比较有显著性差异(P<0.05)。
     结论:
     本次临床试验研究表明,电针夹脊穴及隔附子饼温和灸联合柳氮磺胺吡啶(SASP)组治疗强直性脊柱炎疗效优于柳氮磺胺吡啶组,且副作用的发生率明显降低,有很好的协同作用,确为本病治疗安全有效的方法。对于针灸治疗本病的机理及其远期疗效值得进一步的深入研究。
Objective:
     Through the clinical trial research, the observation of electro-acupuncture (EA) JIAJI points and Aconite cake-separated temperate moxibustion can reduce the poison and increase the efficiency of salicylazosulfapyridine (SASP) ,and it treats the ankylosing spondylitisis's mechanism .Further explores the cooperation of Chinese and Western medicine to treat the ankylosing spondylitisis's security effective scheme.
     Methods:
     1 clinical material: All ankylosing spondylitisis(AS) patient originates from the Wuhan Chinese medicine hospital Rheumatism Branch special clinic and in-patient department. From May, 2007 to February, 2008, altogether admits AS patient 60 examples, uses stochastically,the masculine medicine parallel comparison design method, divides into the experimental group and the control group, experiments the group 30 examples, control group 30 examples.
     2 methods of treatment:①Control group (SASP group): 30 examples, give the salicylazosulfapyridine oral administration, first week each time 0.25g, the second week is 0.5g, the third week was 0.75g finishes until the treatment course, daily 3 times, altogether 12 weeks.②Experimental group (SASP+acupuncture group): 30 examples, above the control group treats gives the electro-acupuncture again and Aconite cake-separated temperate moxibustion, treats 12 weeks later observes the curative effect.③When the few patient joint ache is hard to endure, uses judgment the temporary oral administration loxoprofen, each time 60mg, daily three times, does not make the conventional treatment (symptom to reduce, then stops medicine). In addition, does not use the medicine that treats this sickness related other traditional Chinese medicines and the western medicine.
     3 observation targets: Secure target including common physical examination, heart, lung, liver, kidney function and blood, urine, stool routine and so on ;The curative effect target includes①Cardinal symptoms: The waist shinbone ache, the back ache, the waist keel activity is limited, the lumbodorsal region early morning to be stiff, the joint ache, the joint swelling, the waist knee worn out and aching sleepy heavy, gives off heat.②Main symptom: Visual Analogue Scale, the pillow wall is apart from, refers to is apart from, the Schober experiment, the chest gallery activity, " 4 " the character experiment, the pelvis extrusion, the separation experiment.③Laboratory target: HLA - B27、ESR、CRP、IgA、ALP.④Radioactivity inspection: Two-sided sacroiliac joint X normal position piece.
     4 statistical methods: Uses the SPSS13.0 software package to carry on the data statistical analysis, in the measurement dataset compares uses the pair mean value T-test, the group compares uses two independent sample mean value T-test; The ranked data examines with Ridit, the grouped data uses the chi-square test, P<0.05 was considered examines the difference has statistics significance.
     Results:
     the two group of altogether 60 example patients complete the treatment course, the compliance are good, has not appeared falls off, the rejection case.
     1 After two group of patients treat, the total curative effect passes through the analysis,experimental group total effectiveness 93.33%, will control obviously (near future to control and appearance) rate 66.67%; Control group total effectiveness 76.67%, control obviously leads 40%, two group of total curative effect comparisons have statistics significance (P<0.05).
     2 After two group of patients treat, the Chinese medicine card period of five days curative effect passes through the analysis, the experimental group is always effective is 86.67%, controls obviously leads 56.67%; Control group total effectiveness 76.67%, control obviously leads 22.22%, two group of card period of five days curative effect comparison has statistics significance (P<0.05).
     3 Around the clinical symptoms curative effect aspect, the experimental group treats is quite even has the significance difference (P<0.05); The control group compares the non-significance difference besides the circumference joint swelling item of integral valve treatment around (P>0.05), other each item of host, around the time sickness integral treatment is quite even has the significance difference (P<0.05); After the treatment, the group the comparison, has the significance difference (P<0.05).
     4 Around the main symptom comparison, two group of patient's Visual Analogue Scale, the pillow wall is apart from, refers to is apart from, the Schober experiment and the chest gallery activity aspect, the experimental group treats the comparison to have the significance difference (P<0.05), around the control group treats compares also has the significance difference (P<0.05), and treats the latter two group of patient group the comparison to have the significance difference (P<0.05); "4" the character experiment, the pelvis extrusion, the separation experiment aspect, treats the latter two group of patient group the comparison to have the significance difference (P<0.05).
     5 Around the laboratory target aspect, by ESR, CRP, IgA, ALP takes the observation target, the experimental group treats ESR, CRP, the IgA value to have significance difference (P<0.05), ALP to have the unusual significance difference (P<0.01); Around the control group treats ESR, CRP, IgA, the ALP value to have the significance difference (P<0.05); After the treatment, the group compares ESR, CRP, IgA also to have significance difference (P<0.05), ALP to have the unusual significance difference (P<0.01).
     6 The sacroiliac joint X normal position piece aspect, treats the latter two group of sacroiliac joint X normal position piece change not obvious difference (P>0.05).
     7 After the treatment, the untoward effect aspect, the experimental group 5 example patients present the temporary mild digestive tract to be ill; The control group 2 example patients present the moderate untoward effect, 12 example patients present the mild digestive tract to be ill. Two group of untoward effect situation comparison has the significance difference (P<0.05).
     Conclusion:
     This clinical trial research indicated, the electro-acupuncture (EA) JIAJI points and Aconite cake-separated temperate moxibustion union salicylazosulfapyridine (SASP) the group to treat ankylosing spondylitisis curative effect to surpass salicylazosulfapyridine group, And the side effect formation rate reduces obviously, has the very good synergism, firmly for this sickness treatment safe effective method. Are worth the further deep research regarding the acupunture therapy this sickness's mechanism and the forward curative effect.
引文
[1]杨卫彬.强直性脊柱炎[M].北京:科学技术文献出版社,2005,29.
    [2]郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002年,第一版:119-123.
    [3]王兆铭.中国中西医结合治疗风湿类疾病[M],天津:天津科技出版社,1989年,第一版:542-551.
    [4]蒋明.风湿病学[M].北京:科学出版社1998,第三版:947-949.
    [5]巩桂双.中西医结合治疗强直性脊柱炎的思路[J].中国民政医学杂志,2001,13(1):25-26.
    [6]林文注,王佩.实验针灸学[M].上海:上海科学技术出版社,1999:149-151.
    [7]朱文莲,赵连珠,王佩.艾灸对小鼠巨噬细胞吞噬功能影响的实验观察[J].针刺研究,1999,24(2):143-145.
    [8]杨金洪,赵蓉,袁纪阁等.针刺防治化疗副反应的实验研究:不同穴位的针刺效应比较[J].针刺研究,1994,19(1):75-78.
    [9]潘晓华,许金森,胡翔龙.人体命门穴红外辐射强度初探[J].辽宁中医杂志,2006,33(10):1338-1339.
    [10]廖远新,李金华.附子饼灸对老年人红细胞免疫功能的影响[J].湖南中医学院学报,1996,16(3):42-47.
    [11]朱兆洪,丁柱.单穴与多穴针刺对肾虚动物多脏器自由基代谢的影响[J].浙江中医学院学报,2000,24(4):58-59.
    [12]查炜,尚明华.不同配穴针灸对荷瘤CTX化疗小鼠抗氧化系统的影响[J].南京中医药大学学报·自然科学报,2001,17(5):312-314.
    [13]丁光宏,沈雪勇,褚君浩等.人体穴位与中医各种灸的红外辐射光谱特性[J].针刺研究,2002,27(4):269-273.
    [14]朱林平,徐宗佩.附子的药理作用研究进展[J].中华实用中西医杂志,2004;4(16):2464-2466.
    [15]赵保文.附子、川乌、草乌的炮制加工及药理作用比较[J].首都医药,2000,7(4):33-34.
    [16]王金凯,邢利民,李俊英等.联合用药治疗强直性脊柱炎的临床观察[J].中华风湿病学杂志,1998,2(3):178-179.
    [17]贾红玲,张永臣,单秋华.针刺镇痛的中医理论与西医神经内分泌免疫网络调节[J].针灸临床杂志,2006,22(9):6-7.
    [18]吕玉玲,赵鲁明,陈洪沛等.电针夹脊穴的抗炎镇痛和免疫调节作用[J].中国临床康复.2006,10(19):171-173.
    [19]崇桂琴,马元,孙洪胜等.督灸治疗强直性脊柱炎的临床与镇痛机理研究[J].针灸临床杂志,1999,15(6):46-47.
    [20]李欣,张彦.骨伤科X线诊断学(高等中医院校教材)[M].北京:人民卫生出版社,1991,第二版:189.
    [21]王培昌,钱书虹.新编临床生物化学实验诊断[M].郑州:河南医科大学出版社,1996,第一版:379.
    [1]曾庆馀.关于强直性脊柱炎的早期诊断[J].中华风湿病学杂志,2000,4(2):69-71.
    [2]刘维,张磊,刘滨等.针灸治疗强直性脊柱炎60例疗效观察[J].中国针灸,2002,22(10):665-666.
    [3]李和平.以痛为输报刺法治疗强直性脊柱炎[J].针灸临床杂志,2002,18(4):37.
    [4]龚福英.针灸治疗强直性脊柱炎51例[J].上海针灸杂志,2005,24(5):22.
    [5]曾莉.扬刺夹脊穴治疗强直性脊柱炎[J].湖北中医杂志,2006,28(2):46.
    [6]刘光亭.巨针通督补肾针刺对活动期强直性脊柱炎患者运动能力和疼痛症状的改善作用[J].中国临床康复,2004,8(21):4247.
    [7]胡秋生.长蛇灸治疗强直性脊柱炎89例[J].中国针灸,2002,22(3):176.
    [8]谢延新,苏萍.铺灸疗法配合中药治疗强直性脊柱炎115倒[J].上海针灸杂志,2003,22(6):13.
    [9]冯祯根.铺灸治疗强直性脊柱炎36例[J].上海针灸杂志,2004,23(1):20.
    [10]崇桂琴,马元,孙洪胜等.铺灸治疗强直性脊柱炎的临床研究[J].山东中医杂志,1998,17(5):218-220.
    [11]崇桂琴,马元,孙洪胜等.督灸治疗强直性脊柱炎的临床与镇痛机理研究[J].针灸临床杂志,1999,15(6):46-47.
    [12]胡军勇,陈金亮.从奇络治疗强直性脊柱炎60例临床观察[J].光明中医,2001,16(96):26-27.
    [13]伦新,李万瑶,林剑鸣.蜂针治疗强直性脊柱炎30例[J].四川中医,2000,18(2):41.
    [14]牟秀艳.蜂针治疗强直性脊柱炎29例的疗效观察[J].养蜂科技,2004,3:36-37.
    [15]高广忠,马小平.穴位埋线治疗强直性脊柱炎50例临床分析[J].四川中医,2003,21(5):78-79.
    [16]孙梅,汪涛.药物加穴位埋线治疗强直性脊柱炎[J].实用医药杂志,2006,23(21):172-173.
    [17]王秋云.火针为主治疗强直性脊柱炎外周关节肿12例[J].江苏中医药,2005,26(1):20
    [18]高猛,刘源香.火针并电针治疗强直性脊柱炎117例[J].山东中医杂志.1997,16(7):310.
    [19]马文龙,陈金亮,胡军勇.针药并用治疗强直性脊柱炎108例[J].针灸临床杂志,2000,16(9):13-14.
    [20]刘冠军.中医针法集锦[M].江西:江西科学技术出版社,1988,第一版:60.
    [21]罗健,黄柳和,孔令深等.岭南挑筋法治疗强直性脊柱炎疗效观察[J].针刺研究,2003,28(4):276-279.
    [22]余志辉,胡建芳,黄国明等.挑筋法治疗强直性脊柱炎39例临床观察[J].中国针灸,2004,24(6):375-377.
    [23]陈有国.重刺络放血为主治疗强直性脊柱炎50例[J].江苏中医药,2002,23(7):35.
    [24]马小平.银针灸治疗强直性脊柱炎54例疗效观察[J].上海针灸杂志,2004,23(11):11.
    [25]侯春英,刘强.温针灸治疗强直性脊柱炎33例[J].中医研究,2004,17(3):52-53.
    [26]袁志太.针刺夹脊穴配合推拿治疗强直性脊柱炎23例[J].上海针灸杂志,2003,22(6):3.
    [27]石跃,宋晓光,赵欣纪.针灸配合中药熏蒸治疗强直性脊柱炎30例[J].中国民间疗法2006,14(5):56.
    [28]董洪魁,王建.温针灸配合中药治疗强直性脊柱炎22例[J].中国针灸2006,26(3):172.
    [1]王政,陈湘君.治疗强直性脊柱炎经验[J].辽宁中医杂志,2000,27(5):196.
    [2]赵诗哲,黄仰模.辨治强直性脊柱炎经验[J].浙江中医杂志,2003,38(3):99.
    [3]刘继刚.焦树德教授治疗强直性脊柱炎的经验介绍[J].贵阳中医学院学报,2002,24(9):14-15.
    [4]肖江,吴咏听.浅谈导师治疗强直性脊柱炎的经验[J].云南中医中药杂志,2002,23(5):8-9.
    [5]许东云,方路.舒尚义治疗强直性脊柱炎经验小结[J].云南中医中药杂志,2000,21(1):14-15.
    [6]潘文萍,周丽萍.周翠英治疗强直性脊柱炎的经验[J].四川中医,2002,20(11):1-2.
    [7]陈志军,崔新生,龚环英.中医辨证分型治疗强直性急柱炎疗效观察[J].中国临床康复,2002,24(6):3754-3755.
    [8]关彤.辨证分型治疗强直性脊柱炎33例疗效观察[J].湖南中医杂志,2001,17(3):14-15
    [9]林昌松.陈纪藩教授治疗强直性脊柱炎经验[J].新中医,2001,33(2):10-11.
    [10]袁福林.辨证治疗强直性脊柱炎20例报告[J].中医正骨,2001,13(3):34.
    [11]潘中恒,钱万永,张玄武等.中药配合手法治疗强直性急柱炎76例[J].中医正骨,2001,13(3):25.
    [12]常志遂等.风湿安冲剂对实验性类风湿性关节炎大鼠免疫功能影响的研究[J].中国中医基础医学杂志,2000,6(3):29.
    [13]黄清春等.复方丹参注射液治疗类风湿性关节炎的实验研究[J].新中医,1999,31(2):34.
    [14]胡永红,赖先阳,杨芙蓉等.强直性脊柱炎血液流变性和甲襞微循环检测分析[J].微循环学杂志,2002,12(4):61-62
    [15]卢思俭,王成,尹玉茹.骨痹饮治疗强直性脊柱炎的临床与实验研究[J].中国中西医结合杂志,1999,19(7):390-402.
    [16]苗后清,阎平,刘书珍等.化痰逐瘀解毒汤治疗强直性脊柱炎的临床观察[J].中国中西医结合杂志,2002,22(8):574-576.
    [17]王萧枫,高根德,程春葵等.通痹灵和其它六个方药对强直性脊柱炎成纤维细胞的作用对比[J].中国中医骨伤科杂志,2003,11(1):28-33.
    [18]高根德,刘耀升.强直性脊柱炎棘上棘间韧带成纤维细胞在体外培养中的成骨作用[J].中华风湿病学杂志,1998,2(12):196-199.
    [19]卢瑞丽.独活寄生汤加减治疗强直性脊柱炎35例[J].实用中医药杂志,2003,19(1):10.
    [20]刘五岳,刘鸿鹄.自拟类风宁汤治疗强直性脊柱炎128例[J].湖南中医药导报,2001,7(1):36.
    [21]郑春雷.竹节风汤治疗强直性脊柱炎疗效观察[J].河南中医学院学报,2005,20(3):63-64.
    [22]高天旭,徐立然,弓延振.强柔汤治疗强直性急柱炎62例[J].中国中医药科技,2000,7(1):49-50.
    [23]程永志,高曦,王波.祛痹通络汤治疗强直性脊柱炎疗效观察[J].黑龙江中医药,2003,31(2):42.
    [24]刘明淮,龙翔宇.正清风痛宁治疗强直性脊柱炎67例疗效观察[J].中药新药与临床药理,2002,13(3):147.
    [25]朱跟葵,付俏芳.益肾蠲痹丸治疗强直性脊柱炎23例疗效观察[J].浙江临床医学,2003,5(7):556.
    [26]石朝云.中医治疗强直性脊柱炎研究进展[J].光明中医,2002,17(5):39-43.
    [27]刘维,张磊,刘滨等.针灸治疗强直性脊柱炎60例疗效观察[J].中国针灸,2002,22(10):665-666.
    [28]刘光亭.巨针通督补肾针刺对活动期强直性脊柱炎患者运动能力和疼痛症状的改善作用[J].中国临床康复,2004,8(21):4247.
    [29]谢延新,苏萍.铺灸疗法配合中药治疗强直性脊柱炎115倒[J].上海针 灸杂志,2003,22(6):13.
    [30]伦新,李万瑶,林剑鸣.蜂针治疗强直性脊柱炎30例[J].四川中医,2000,18(2):41.
    [31]高广忠,马小平.穴位埋线治疗强直性脊柱炎50例临床分析[J].四川中医,2003,21(5):78-79.
    [32]马文龙,陈金亮,胡军勇.针药并用治疗强直性脊柱炎108例[J].针灸临床杂志,2000,16(9):13-14.
    [33]陈有国.重刺络放血为主治疗强直性脊柱炎50例[J].江苏中医药,2002,23(7):35.
    [34]罗健,黄柳和,孔令深等.岭南挑筋法治疗强直性脊柱炎疗效观察[J].针刺研究,2003,28(4):276-279.
    [35]袁志太.针刺夹脊穴配合推拿治疗强直性脊柱炎23例[J].上海针灸杂志,2003,22(6):3.
    [36]石跃,宋晓光,赵欣纪.针灸配合中药熏蒸治疗强直性脊柱炎30例[J].中国民间疗法,2006,14(5):56.
    [37]张乃峥.临床风湿病学[M],上海:上海科学出版社,1999,第一版:156-173.
    [38]厉小梅,李向培,汪国生.关节炎患者血清肿瘤坏死因子a的检测及意义[J].安徽医学,2002,23(6):12-13.
    [39]董怡,张卓莉.白细胞介素-1家族在类风湿关节炎和骨关节炎中的作用[J].中华风湿病学杂志,2004,8(5):257-258.
    [40]GrataeosJ,ColladoA,PonsF etal.Signifieant loss of bone mass in patients with early,active ankylosing spondylitis:a follow up study[J].Arthritis Rheum,1999,42(11):2319-2324.
    [41]古洁若,张汉伟,黄锋等.基质金属蛋白酶-3在强直性脊柱炎中的作用和意义探讨[J].中国药物与临床,2004,4(4):270-276.
    [42]古洁若,黄烽,颜光美等.Remicade调节强直性脊柱炎患者滑膜细胞基因表达谱的初步研究[J].中华风湿病学杂志,2003,7(10):591-595.
    [43]TomoyasuA,Goto M,Fujise N etal.Charaeterization of monomeric and Homodimerc forms of osteoclastogenesis inhibitory factors[J].Biochem BioPhys Res Com,1998,24(5):382-387.
    [44]Gravallese Em,Manning c,Tsay A etal.Synovial tissue in rheumatoid Arthritis is a souce of osteoclast differenitiation factor[J].Arthritis Rheum,2000,43(1):250.
    [45]Yukio S,Thomas P,Peter K etal.Expression of osteoclast fifferentiation faetor in rheumatoid arthritis[J].Arthritis Rheum,2000,43(1):2523.
    [46]Takayanagi H,Iizuka H,Juji T etal.Involvement of recptor activator of nuclear factor kB ligand osteoclast fifferentiation factor in osteoclastogenesis from synovioeytes in rheumatoid arthritis[J].Arthritis Rheum,2000,43(1):259.
    [47]Kurt R,Silvia H,Andrea M etal.Tumor necrosis factor a-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin [J].Arthritis Rheum,2002,46(2):785.
    [48]曾晓峰,赵建宁.骨代谢与免疫功能的相互调节[J].细胞与分子免疫学杂志,2003,19(6):629-632.
    [49]赵伟,黄锋.细胞核因子KB受体活化因子配基在强直性脊柱炎的表达及意义[J].解放军医学杂志,2004,29(6):482-485.
    [50]中华医学会风湿病学分会.强直性脊柱炎诊治指南(草案)[J].中华风湿病学杂志,2003,7(10):641-644.
    [51]Breban M,Gombert B,Amor B,etal.Efficacy of thalidomide in the treatment of refractory ankylosing spondylitis[J].Arthritis Rheum.1999,42:580-581.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700